News
CEP for Baclofen available
02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of Medicines (EDQM) for Baclofen
Polpharma Fine Chemicals Business Unit is a holder of 8 CEPs, 32 US DMFs, 156 EU DMFs (including 87 applicant`s and 69 restricted parts of EU DMF).
Latest news
CEP for Baclofen available
Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...
Polpharma – the most innovative company in Poland
Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex
Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...
Co-operation between Polpharma and RPG Life Sciences
Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...